Olympus: $270 Million BioProtect Acquisition Expands Urology And Prostate Cancer Portfolio - Pulse 2.0
HealthcareAdd-on
Olympus→BioProtect
May 27, 2026
Olympus — Acquisitions & M&A Deals
4 dealsTracking 4 M&A deals by Olympus.
Olympus to acquire BioProtect in $270 million deal focused on prostate cancer care - DOTmed
HealthcarePlatform
Olympus→BioProtect
May 27, 2026
Olympus to acquire urologic balloon spacer maker BioProtect for $270M - MassDevice
HealthcareMerger
Olympus→BioProtect
May 26, 2026
Olympus to Acquire BioProtect to Expand Its Portfolio of Urological Technologies and Address Prostate Cancer - PR Newswire
HealthcarePlatform
Olympus→BioProtect
May 26, 2026